Om Megashree Pharmaceuticals IPO Opened for General Public

After completing the first phase of IPO allocation for Nepalese workers abroad. Om Megashree Pharmaceuticals Limited has opened its Initial Public Offering (IPO) for the general public starting today, 27th Falgun, 2081.

The company is issuing 14,76,000 unit shares at a par value of Rs. 100 per share. The early closing date for the IPO is 3rd Chaitra, 2081, with a possible extension to 12th Chaitra, 2081, if the issue remains unsubscribed.

Key Highlights of the IPO

Particulars	Details
IPO Opening Date	27th Falgun, 2081
Early Closing Date	3rd Chaitra, 2081
Extended Closing Date	12th Chaitra, 2081 (if unsubscribed)
Total Units for Public	1,476,000 units
Par Value per Share	Rs. 100
Application Range	Min: 10 units, Max: 10,000 units
Issue Manager	Prabhu Capital Limited
CARE Ratings	CARE-NP BB- (Is) (Moderate Default Risk)

IPO Details and Allocation

Total Issued Capital: Rs. 60 Crores.
Public Issue: 30% (18,00,000 units worth Rs. 18 Crores).
- Nepalese Citizens Working Abroad: 10% (1,80,000 units).
- Mutual Funds: 5% (90,000 units).
- Company Employees: 3% (54,000 units).
- General Public: 14,76,000 units (remaining 82%).

Issue Manager

Prabhu Capital Limited has been appointed as the issue manager for the IPO. They will oversee the application process and ensure compliance with regulatory requirements.

CARE Ratings Nepal’s Reaffirmation

CARE Ratings Nepal Limited (CRNL) has reaffirmed the following ratings for Om Megashree Pharmaceuticals Limited:

Issuer Rating: ‘CARE-NP BB- (Is)’ – indicating a moderate risk of default in meeting financial obligations.
Long-term Bank Facilities: ‘CARE-NP BB-’.
Short-term Bank Facilities: ‘CARE-NP A4’.

These ratings reflect the company’s financial stability and operational capabilities.

About Om Megashree Pharmaceuticals Limited

Establishment: June 12, 2016.
Type: Public Limited Company.
Operations: Manufacturing pharmaceutical products at its plant in Chitwan.
Partial Operations Started: February 19, 2024.

Conclusion

Om Megashree Pharmaceuticals Limited’s IPO presents an opportunity for the general public to invest in a growing pharmaceutical company with a strong foundation. With a moderate default risk rating and a clear allocation plan, the IPO is poised to attract investor interest. Interested individuals can apply for shares starting today, 27th Falgun, 2081, through the designated issue manager, Prabhu Capital Limited.